These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30428847)

  • 61. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.
    Thio CL; Smeaton L; Hollabaugh K; Saulynas M; Hwang H; Saravanan S; Kulkarni S; Hakim J; Nyirenda M; Iqbal HS; Lalloo UG; Campbell TB; Lockman S; Currier JS
    AIDS; 2015 Jun; 29(10):1173-82. PubMed ID: 26035319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan.
    Lin JJ; Lin KY; Tang HJ; Lin SP; Lee YC; Liu CE; Huang YS; Wang NC; Li CW; Ko WC; Yang HJ; Lee YT; Hung CC;
    J Microbiol Immunol Infect; 2021 Apr; 54(2):228-237. PubMed ID: 31708481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.
    Ingiliz P; Valantin MA; Thibault V; Duvivier C; Dominguez S; Katlama C; Poynard T; Benhamou Y
    Antivir Ther; 2008; 13(7):895-900. PubMed ID: 19043923
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.
    van Bömmel F; Trojan J; Deterding K; Wedemeyer H; Wasmuth HE; Hüppe D; Möller B; Bock FJ; Feucht HH; Berg T
    Antivir Ther; 2012; 17(6):1049-58. PubMed ID: 22892524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment.
    Liu Y; Corsa AC; Buti M; Cathcart AL; Flaherty JF; Miller MD; Kitrinos KM; Marcellin P; Gane EJ
    J Viral Hepat; 2017 Jan; 24(1):68-74. PubMed ID: 27658343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
    Zhu Y; Curtis M; Qi X; Miller MD; Borroto-Esoda K
    Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
    Katz LH; Tur-Kaspa R; Guy DG; Paul M
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection.
    Tsai WC; Hsu WT; Liu WD; Sun HY; Chuang YC; Huang YS; Cheng A; Lin KY; Huang YC; Chen GJ; Huang SH; Sheng WH; Hsieh SM; Hung CC; Chang SC
    Liver Int; 2019 Aug; 39(8):1408-1417. PubMed ID: 30712284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen.
    Mata-Marín JA; Mata-Marín LA; Arroyo-Anduiza CI; Huerta-García G; Sandoval-Ramirez JL; Manjarrez-Tellez B; Gaytán-Martínez JE
    Hepatogastroenterology; 2014; 61(133):1187-91. PubMed ID: 25436280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
    Hawkins C; Kang M; Bhattacharya D; Cloherty G; Kuhns M; Matining R; Thio C; Samaneka W; Chinula L; Mulinda N; Badal-Faesen S; Sugandhavesa P; Lama J; Gaseitsiwe S; Holzmayer V; Anderson M; Murphy R; Peters M
    AIDS; 2022 Jun; 36(7):975-984. PubMed ID: 35165216
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
    Audsley J; Arrifin N; Yuen LK; Ayres A; Crowe SM; Bartholomeusz A; Locarnini SA; Mijch A; Lewin SR; Sasadeusz J
    HIV Med; 2009 Apr; 10(4):229-35. PubMed ID: 19178592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia.
    Seang S; Detruchis P; Todesco E; Valantin MA; Schneider L; Palich R; Peytavin G; Pourcher V; Marcelin AG; Katlama C
    Infect Dis Now; 2024 Oct; 54(7):104980. PubMed ID: 39313158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
    Boyd A; Gozlan J; Maylin S; Delaugerre C; Peytavin G; Girard PM; Zoulim F; Lacombe K
    Hepatology; 2014 Aug; 60(2):497-507. PubMed ID: 24752996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
    van Bömmel F; de Man RA; Wedemeyer H; Deterding K; Petersen J; Buggisch P; Erhardt A; Hüppe D; Stein K; Trojan J; Sarrazin C; Böcher WO; Spengler U; Wasmuth HE; Reinders JG; Möller B; Rhode P; Feucht HH; Wiedenmann B; Berg T
    Hepatology; 2010 Jan; 51(1):73-80. PubMed ID: 19998272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
    Wang GL; Liu Y; Qiu P; Zhou SF; Xu LF; Wen P; Wen JB; Xiao XZ
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):866-72. PubMed ID: 27010143
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adefovir and lamivudine combination therapy in patients with entecavir-resistant chronic hepatitis B: antiviral responses and evolution of mutations.
    Yim HJ; Lee HJ; Suh SJ; Seo YS; Kim CW; Lee CD; Park SH; Lee MS; Park CK; Chae HB; Kim MY; Baik SK; Kim YS; Kim JH; Lee JI; Lee JW; Hong SP; Um SH
    Intervirology; 2014; 57(5):239-47. PubMed ID: 24993731
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B Virus (HBV) Load Response to 2 Antiviral Regimens, Tenofovir/Lamivudine and Lamivudine, in HIV/ HBV-Coinfected Pregnant Women in Guangxi, China: The Tenofovir in Pregnancy (TiP) Study.
    Wang L; Wiener J; Bulterys M; Wei X; Chen L; Liu W; Liang S; Shepard C; Wang L; Wang A; Zhang F; Kourtis AP
    J Infect Dis; 2016 Dec; 214(11):1695-1699. PubMed ID: 27658693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
    Kiweewa FM; Tierney C; Butler K; Peters MG; Vhembo T; Moodley D; Govender V; Mohtashemi N; Ship H; Musoke P; Dula D; George K; Chakhtoura N; Fowler MG; Currier JS; Bhattacharya D
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):79-84. PubMed ID: 35621877
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Levy V; Grant RM
    Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.